World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
46
Citations
8023
World Ranking
4904
National Ranking
1895

Krisztina M. Papp-Wallace publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Krisztina M. Papp-Wallace sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 134 publications — 18th percentile

18% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Krisztina M. Papp-Wallace D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Krisztina M. Papp-Wallace sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 46 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Krisztina M. Papp-Wallace is a researcher affiliated with Case Western Reserve University in the United States. Their work spans several fields with a strong focus on biochemical and medical aspects of infectious diseases and antibiotic resistance.

The primary fields of study in their research include Biochemistry, Genetics and Molecular Biology and Medicine. Subfields of particular interest are Molecular Medicine, Pharmacology, Epidemiology, Molecular Biology, and Endocrinology, reflecting a multidisciplinary approach to understanding bacterial resistance and treatment strategies.

The main research topics covered by their work are:

  • Antibiotic Resistance in Bacteria
  • Antibiotics Pharmacokinetics and Efficacy
  • Bacterial biofilms and quorum sensing
  • Burkholderia infections and melioidosis
  • Plant Pathogenic Bacteria Studies
  • Antibiotic Use and Resistance
  • Vibrio bacteria research studies

Several frequent coauthors collaborate regularly with this researcher, including:

  • Robert A. Bonomo (36 coauthored works)
  • Christopher R. Bethel (18 coauthored works)
  • Focco van den Akker (13 coauthored works)
  • Scott A. Becka (12 coauthored works)
  • Elise T. Zeiser (11 coauthored works)

The most frequent publication venues for their research are:

  • Antimicrobial Agents and Chemotherapy (16 publications)
  • Open Forum Infectious Diseases (7 publications)
  • Antibiotics (4 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (3 publications)
  • mBio (2 publications)

Important research papers include:

  • Resistance to Novel β-Lactam-β-Lactamase Inhibitor Combinations, 2020, Infectious Disease Clinics of North America
  • Structural Characterization of the D179N and D179Y Variants of KPC-2 β-Lactamase: Ω-Loop Destabilization as a Mechanism of Resistance to Ceftazidime-Avibactam, 2022, Antimicrobial Agents and Chemotherapy
  • Cerebrospinal fluid (CSF) augments metabolism and virulence expression factors in Acinetobacter baumannii, 2021, Scientific Reports
  • Durlobactam, a Broad-Spectrum Serine β-lactamase Inhibitor, Restores Sulbactam Activity Against Acinetobacter Species, 2023, Clinical Infectious Diseases
  • A γ-Lactam Siderophore Antibiotic Effective against Multidrug-Resistant Gram-Negative Bacilli, 2020, Journal of Medicinal Chemistry

Best Publications

  • Carbapenems: Past, Present, and Future

    Krisztina M. Papp-Wallace;Andrea Endimiani;Andrea Endimiani;Andrea Endimiani;Magdalena A. Taracila;Robert A. Bonomo

  • New β-Lactamase Inhibitors: a Therapeutic Renaissance in an MDR World

    Sarah M. Drawz;Krisztina M. Papp-Wallace;Krisztina M. Papp-Wallace;Robert A. Bonomo

  • Manganese Transport and the Role of Manganese in Virulence

    Krisztina M. Papp-Wallace;Michael E. Maguire

  • Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?

    Steven Marshall;Andrea M. Hujer;Andrea M. Hujer;Laura J. Rojas;Laura J. Rojas;Krisztina M. Papp-Wallace

  • Inhibitor Resistance in the KPC-2 β-Lactamase, a Preeminent Property of This Class A β-Lactamase

    Krisztina M. Papp-Wallace;Christopher R. Bethel;Anne M. Distler;Courtney Kasuboski

  • New β-Lactamase Inhibitors in the Clinic

    Krisztina M. Papp-Wallace;Robert A. Bonomo

  • Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply “precision medicine” to antimicrobial chemotherapy?

    Federico Perez;Nadim G El Chakhtoura;Krisztina M Papp-Wallace;Brigid M Wilson

  • Strategic Approaches to Overcome Resistance against Gram-Negative Pathogens Using β-Lactamase Inhibitors and β-Lactam Enhancers: Activity of Three Novel Diazabicyclooctanes WCK 5153, Zidebactam (WCK 5107), and WCK 4234

    Krisztina M. Papp-Wallace;Nhu Q. Nguyen;Michael R. Jacobs;Christopher R. Bethel

  • WCK 5107 (Zidebactam) and WCK 5153 Are Novel Inhibitors of PBP2 Showing Potent "β-Lactam Enhancer" Activity against Pseudomonas aeruginosa, Including Multidrug-Resistant Metallo-β-Lactamase-Producing High-Risk Clones.

    Bartolome Moya;Isabel M. Barcelo;Sachin Bhagwat;Mahesh Patel

  • Unexpected Challenges in Treating Multidrug-Resistant Gram-Negative Bacteria: Resistance to Ceftazidime-Avibactam in Archived Isolates of Pseudomonas aeruginosa

    Marisa L. Winkler;Krisztina M. Papp-Wallace;Andrea M. Hujer;T. Nicholas Domitrovic

  • Klebsiella pneumoniae Carbapenemase-2 (KPC-2), Substitutions at Ambler Position Asp179, and Resistance to Ceftazidime-Avibactam: Unique Antibiotic-Resistant Phenotypes Emerge from β-Lactamase Protein Engineering.

    Melissa D. Barnes;Melissa D. Barnes;Marisa L. Winkler;Marisa L. Winkler;Magdalena A. Taracila;Magdalena A. Taracila;Malcolm G. Page

  • Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop

    Marisa L. Winkler;Krisztina M. Papp-Wallace;Robert A. Bonomo

  • The latest advances in β-lactam/β-lactamase inhibitor combinations for the treatment of Gram-negative bacterial infections.

    Krisztina M. Papp-Wallace

  • Deciphering the evolution of cephalosporin resistance to ceftolozane-tazobactam in pseudomonas aeruginosa

    Melissa D. Barnes;Melissa D. Barnes;Magdalena A. Taracila;Magdalena A. Taracila;Joseph D. Rutter;Christopher R. Bethel

  • Resistance to Novel β-Lactam-β-Lactamase Inhibitor Combinations: The "Price of Progress".

    Krisztina M. Papp-Wallace;Andrew R. Mack;Magdalena A. Taracila;Robert A. Bonomo

  • Targeting Multidrug-Resistant Acinetobacter spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic Agent.

    Melissa D. Barnes;Melissa D. Barnes;Vijay Kumar;Christopher R. Bethel;Samir H. Moussa

  • Non-phenotypic tests to detect and characterize antibiotic resistance mechanisms in Enterobacteriaceae.

    Agnese Lupo;Krisztina M. Papp-Wallace;Krisztina M. Papp-Wallace;Parham Sendi;Robert A. Bonomo;Robert A. Bonomo

  • Variants of β-Lactamase KPC-2 That Are Resistant to Inhibition by Avibactam

    Krisztina M. Papp-Wallace;Marisa L. Winkler;Magdalena A. Taracila;Magdalena A. Taracila;Robert A. Bonomo

  • Relebactam Is a Potent Inhibitor of the KPC-2 β-Lactamase and Restores Imipenem Susceptibility in KPC-Producing Enterobacteriaceae

    Krisztina M. Papp-Wallace;Krisztina M. Papp-Wallace;Melissa D. Barnes;Melissa D. Barnes;Jim Alsop;Magdalena A. Taracila;Magdalena A. Taracila

  • Beyond Piperacillin-Tazobactam: Cefepime and AAI101 as a Potent β-Lactam-β-Lactamase Inhibitor Combination.

    Krisztina M Papp-Wallace;Christopher R Bethel;Jocelyne Caillon;Melissa D Barnes;Melissa D Barnes

  • Exploring the Role of a Conserved Class A Residue in the Ω-Loop of KPC-2 β-Lactamase A MECHANISM FOR CEFTAZIDIME HYDROLYSIS

    Peter S. Levitt;Krisztina M. Papp-Wallace;Magdalena A. Taracila;Andrea M. Hujer

  • Novel β-lactamase inhibitors: a therapeutic hope against the scourge of multidrug resistance

    Richard Watkins;Krisztina M. Papp-Wallace;Sarah M. Drawz;Robert Anthony Bonomo

  • Molecular Investigations of PenA-mediated β-lactam Resistance in Burkholderia pseudomallei.

    Drew A. Rholl;Krisztina M. Papp-Wallace;Andrew P. Tomaras;Michael L. Vasil

Frequent Co-Authors

Robert A. Bonomo
Robert A. Bonomo Case Western Reserve University
Michael R. Jacobs
Michael R. Jacobs University Hospitals of Cleveland
Robert A. Bonomo
Robert A. Bonomo Case Western Reserve University
Kristine M. Hujer
Kristine M. Hujer Case Western Reserve University
Federico Perez
Federico Perez Case Western Reserve University
Andrea M. Hujer
Andrea M. Hujer United States Department of Veterans Affairs
John J. LiPuma
John J. LiPuma University of Michigan–Ann Arbor
Marcelo E. Tolmasky
Marcelo E. Tolmasky California State University, Fullerton
Alejandro J. Vila
Alejandro J. Vila National University of Rosario
Andrea Endimiani
Andrea Endimiani University of Bern

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in microbiology, expanding your expertise with complementary online degrees can open diverse career opportunities. For example, the shortest online medical billing and coding certificate programs are ideal for professionals looking to quickly upskill in healthcare administration, blending scientific knowledge with medical office capabilities.

If you are considering advancing your qualifications in the medical field, exploring what medical degree can I get online is a valuable step. While direct clinical degrees may have limited online options, many related healthcare degrees offer flexible online pathways that complement microbiology expertise.

Public health is also a natural extension of microbiology studies. Programs like mph online programs with easy admission requirements provide accessible avenues for professionals interested in epidemiology, health policy, or environmental health, fields where microbiological knowledge is crucial.

Career paths such as child life specialists highlight the importance of interdisciplinary skills. Understanding how much does a child life specialist make can guide decisions about combining microbiology with child healthcare services, enhancing your impact in clinical and community environments.

Best Scientists Citing Krisztina M. Papp-Wallace

Trending Scientists

Recently Published Articles